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Abstract
With the increasing lifespan of human, cardiovascular diseases (CVDs) and 
cancer are the main diseases leading to the death in the world. Aging is related 
to a progressive decline in cardiovascular function and structure. While human 
body suffer from oxidative stress, reactive oxygen species (ROS) are generated as 
metabolic by-products, which lead to inactivate proteins, damage nucleic acids, and 
alter the fatty acids of lipids. The accumulation of this oxidative damage contributes 
to the development of heart disease, diabetes, chronic inflammatory diseases, and 
cancer. Polyphenols have been widely studied as an anti-oxidant agent in the world. 
Danshen, the dried root or rhizome of Salvia miltiorrhiza Bunge. is a common 
Traditional Chinese medicine used in cardiovascular disease and cancer. The main 
polyphenols in Danshen are phenolic acids (including Salvianolic acids A and B, 
rosmarinic acid, and their derivatives) and flavonoids. Salvianolic acids have potent 
anti-oxidative capabilities due to their polyphenolic structure and exhibit cardio-
vascular protection through mechanisms of ROS scavengers, reduction of leuko-
cyte-endothelial adherence, inhibition of inflammation and indirect regulation of 
immune function. Salvianolic acids A and B have been reported to owe anti-cancer, 
anti-inflammatory activities not only through inducing apoptosis, halting cell cycle 
and adjourning metastasis by targeting multiple deregulated signaling networks of 
cancer but also sensitizing cancer cells to chemotherapeutic agents.
Keywords: Salvia miltiorrhiza, polyphenol, Traditional Chinese medicine, 
cardiovascular disease, cancer
1. Introduction
With the increasing lifespan of human, cardiovascular diseases (CVDs) and 
cancer are the main diseases leading to the death in the world [1]. Aging is related 
to a progressive decline in cardiovascular function and structure. The major CVDs 
include ischemic heart disease, cardiomyopathy, hypertensive heart disease, atrial 
fibrillation, stroke, aortic aneurysm, rheumatic heart disease, endocarditis, and 
peripheral arterial disease [2].
There are many oxidants surrounding our environment even persisted inside 
the human body. While human body suffer from oxidative stress, reactive oxygen 
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species (ROS) are produced from the respiratory chain and leading the electron 
transfer. Superoxide radical (O2
•–) which dismutates from hydrogen peroxide (H 
2O2) and molecular oxygen (O2) is a toxic compound after the ROS stimulation [3, 
4]. ROS are related to inactivate proteins, damage nucleic acids, and alter the fatty 
acids of lipids. When those oxidative intracellular components in turn to pertur-
bations in membrane structure and function, those reaction might lead to cell 
damage. The accumulation of this oxidative damage for a long period of time will 
leading the development of heart disease, diabetes, chronic inflammatory diseases, 
cancer, and several neurodegenerative diseases in the aging process.
Polyphenols have been widely studied as an anti-oxidant agent in the world. 
They are common nutrient antioxidants, mainly derived from fruits, vegetables, 
tea, coffee, cocoa, mushrooms, beverages, and Traditional Chinese medicine [5, 
6]. Traditional Chinese medicine (TCM) are widely used for a long time in Asia 
countries. Most TCM source come from plants, including leaf, stem, roots or whole 
plants. Polyphenols are content rich in plants, and so are TCM. Danshen, the dried 
root or rhizome of Salvia miltiorrhiza Bunge. is a common TCM used in cardio-
vascular disease and cancer [7–9]. Following, we will make a discussion of aging-
associated CVDs, cancer and Salvia miltiorrhiza (Danshen).
2.  The monographs of aging-associated cardiovascular disease, cancer 
and Salvia miltiorrhiza
2.1 Aging-associated cardiovascular disease
The epidemic of CVDs has taken on a global dimension. CVDs now represent 
more than 30% of all deaths worldwide. According to the World Health Report, 
CVDs were responsible for 15 million annual deaths worldwide. Especially in devel-
oping countries, 9 million deaths every year while 2 million deaths in economies in 
transition [10].
CVD is positive related to human’s age. By 2030, approximately 20% of the 
population will be aged 65 or older. At that time, the prevalence of CVD will expo-
nential increase due to the fact that additional 27 million people will have hyperten-
sion, 8 million coronary heart disease, 4 million stroke and 3 million heart failure 
[11]. In this age group, CVDs will result in 40% of all deaths and rank as the leading 
cause and cost triple payment for treatment [12, 13].
Consistently, researchers have found that many of the factors underlying age-
related changes in the arteries are also implicated in the development of CVD [14]. 
The incidence and prevalence of common CVDs such as hypertension, atheroscle-
rosis, coronary and cerebral artery disease are increasing at about age 45 in men and 
age 55 in women [15]. These diseases may develop to increase in the prevalence of 
congestive heart failure and stroke during aging.
Aging is accompanied by changes in vascular structure and function, especially 
in the large arteries [16]. The aging cardiovascular tissues are exemplified by 
pathological alterations including hypertrophy, altered left ventricular (LV) dia-
stolic function, and diminished LV systolic reverse capacity [17], increased arterial 
stiffness, and impaired endothelial function.
Endothelial dysfunction [18] is one of the major pathologic change of CVDs, 
besides, increasing intima media thickness, vascular stiffness [19], vesicular smooth 
muscle cells hypertrophy and proliferation and increasing vessel diameter are 
related to aging vessels. Impaired endothelial vasodilation is an early sign of arterial 
aging before the clinical manifestations of vascular dysfunction [20]. As endothelial 
cells age, they exhibit a reduction in endothelial nitric oxide synthetase (eNOS) 
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activity, reducing the abundance of nitric oxide (NO) [21]. NO is a vasodilator pro-
duced by endothelial cells, and related to regulate vascular tone, inhibiting vascular 
inflammation, thrombotic events, and aberrant cellular proliferation [22].
Aging has also a remarkable effect on the heart [23]. The number of cardiac 
myocytes lessen while heart weight gains with age. The functional cardiac cell 
continued loss come with the lower regenerative activity from 1% to 0.4% per year 
of age 20 to 75 years [24]. Most of researches found no obvious difference between 
male and female in increasing atrial volume [25] and cardiac fibrosis [26]. Although 
one study of cardiac extracellular matrix proteins found that senior women had a 
greater amount of collagen and other extracellular matrix proteins in the LV than 
senior men [27]. A recent work has clearly demonstrated that age-dependent mito-
chondrial DNA damage is an important substrate underpinning the pathophysiol-
ogy of cardiac arrhythmias [28]. Another important pathological feature associated 
with aging is the calcification of aortic and mitral valves which triggers stenosis/
insufficiency resulting in cardiac pressure/volume overload [29].
2.2 Cancer
Cancer is the second leading cause of death globally after ischemic heart disease, 
accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018 and 
accounting for nearly 10 million deaths in 2020, but will likely become the first for 
nearly 18.63 million deaths in 2060 [30, 31]. Lung, prostate, colorectal, stomach and 
liver cancer are the most common types of cancer in men, while breast, colorectal, 
lung, cervical and thyroid cancer are the most common among women. It might 
prevent about one-third to half of cancer death after modifying or avoiding key risk 
factors and reduce the cancer burden through early detection of cancer. Prevention 
is the most important and effective long-term strategy for cancer control [32].
Cancer is a multistage process that involves mutational changes and uncon-
trolled cell proliferation. The etiology of cancer is linked to environmental and 
genetic inheritance causes. The physical (such as ultraviolet and ionizing radia-
tion), chemical (such as asbestos, components of tobacco smoke, aflatoxin, and 
arsenic) and biological carcinogens (infections from certain viruses, bacteria, or 
parasites) may play a role in tumor genesis. The accumulation of molecular dam-
age in DNA, proteins and lipids during the aging progress is also characterized by 
an increase in intracellular oxidative stress due to the progressive decrease of the 
intracellular ROS scavenging [33]. Therefore, oxidative stress and the resulting 
oxidative damage are important contributors to the formation and progression of 
cancer [34].
2.3 Bioactive components of Salvia miltiorrhiza (Danshen)
Salvia miltiorrhiza (Danshen) belongs to the Lamiaceae family. There are at least 
49 diterpenoid quinones, more than 36 hydrophilic phenolic acids, and 23 essential 
oil constituents have been isolated and identified from Danshen [35]. Our previous 
population-based studies demonstrated that Danshen is the most common herbal 
drug used to treat ischemic heart disease [36] and ischemic stroke [37].
The predominant bioactive compounds in Danshen contains two major groups 
of chemicals [8, 38]. The first group includes lipophilic compounds (Terpenoids) 
such as tanshinone I, tanshinone IIA, acetyltanshinone IIA, cryptotanshinone, 
isocryptotanshinone, dihydrotanshinone, 15,16-dihydrotanshinone I, and miltirone 
(Figure 1b). These terpenoids possess a wide range of biological activities includ-
ing antioxidant [39], antibacterial [40], anti-inflammatory [41], antiatherogenic, 
neuroprotective [42], antitumor [43, 44], and antidiabetic [39] effects.
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The second group includes the hydrophilic phenolic acids such as caffeic 
acid, danshensu, salvianolic acid A(SalA), salvianolic acid B(SalB), lithosper-
mic acid and lithospermic acid B (Figure 1b). Tanshinones show antibacterial, 
antioxidant, and antineoplastic activities, whereas phenolic acids possess more 
antioxidant and anticoagulant activities [45]. The classification of polyphenols 
mainly includes flavonoids (60%), phenolic acids (30%), and other polyphenols 
(including stilbenes and lignans) [46]. The main polyphenols in Danshen are 
phenolic acids (including SalA, SalB, rosmarinic acid, and their derivatives) and 
flavonoids, which exhibit anti-oxygenation, anti-ischemia–reperfusion injury, 
anti-thrombosis, anti-tumor, and other therapeutic effects [47]. The main poly-
phenolic compounds are based on caffeic acid (3,4-dihydroxycinnamic acid), one 
of the most common phenolic acids, formed from two to four or more caffeic acid 
units, is one of the most common phenolic acids, frequently exist in fruits, grains, 
as well as TCM [48].
Figure 1. 
The chemical structures of major (a) lipophilic terpenoids and (b) hydrophilic phenolic acids of Danshen.
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3. Oxidative stress in aging-associated cardiovascular disease and cancer
3.1 Oxidative stress and aging-associated cardiovascular disease
Decreasing in absolute number of cardiomyocytes due to increased apoptosis 
and necrosis and decreasing in repopulation of cardiomyocytes from cardiac stem 
cell reserves were occurred in aging heart [49, 50]. The increase in oxidative stress 
due to the increase in ROS production with age results in an overall enhancement 
in the rate of cardiomyocyte death with age. With advancing age, we accumulate 
mutations in our somatic cells. The expression of such factors as p53, p21, p16, 
senescence-associated β-galactosidase activity and phosphorylation status of 
γ-H2Ax are widely used to detect the DNA damage. These biomarkers of aging can 
be used in cardiac tissue to assess how modulation of longevity genes influences the 
rate and degree of cardiovascular aging at the cellular level [51, 52].
Many aging-associated CVDs including ischemia/reperfusion, hypertensive 
heart disease and diabetes are related to oxidative stress and that will exhibit 
cytokines. In addition, increased ROS-responsive signaling pathways are objective 
by inflammatory oxidative stress and ROS generative system like unfolded protein 
response of the endoplasmic reticulum or NADPH oxidase activation [53].
The Apoptosis signal-regulating kinase 1(ASK1)-signalosome regulates p38 
MAPK and SAPK/JNK and NFκB signaling networks promote senescence (in vitro) 
and aging (in vivo, animal models and human cohorts) in response to oxidative 
stress and inflammation leading to age-associated CVDs. Furthermore, their inhibi-
tion delays the onset of these CVDs as well as senescence and aging [53, 54].
The Energy generation from mitochondria is through oxidative phosphorylation 
and will also increase in ROS production which leads to free radical–imposed dam-
age to macromolecules and cellular component. p66Shc, a mitochondrial adaptor, 
plays an important role in the generation of ROS and as a molecular effector which 
may explain how aging is connected with CVD and metabolic disease [55]. Several 
studies show that increased p66Shc expression with time may promote ROS accu-
mulation with subsequent deregulation of pathways implicated in mitochondrial 
dysfunction, fat accumulation, insulin resistance and diabetes [56–58].
The AMPK-SIRT1 pathway is involved in energy metabolism in cell. The func-
tional AMP-activated protein kinase (AMPK) is a heterotrimer consisting of a 
catalytic alpha (α), a regulatory gamma (γ) and a scaffolding beta (β) subunit and 
is activated by low cellular energy status [59]. AMPK activates eNOS, and facilitates 
autophagy and mitophagy, thus preventing mitochondrial insufficiency, inflamma-
tion and cellular death [60]. Sirtuin 1 (SIRT1) is a NAD+-dependent class III histone 
deacetylase (HDAC) that mediates the effects of caloric restriction on lifespan and 
metabolic pathways in various organisms. SIRT1 prevents cardiovascular aging by 
activating of eNOS [61].
3.2 Oxidative stress in cancer
Cancer is a multistage process defined by at least three stages: initiation, promo-
tion, and progression [62]. ROS from both endogenous and exogenous sources result 
in increased oxidative stress in the cell. Oxidative stress modulates gene expression 
of downstream targets involved in DNA repair, cell proliferation and in part through 
activation or inhibition of transcription factors and second messengers. The role of 
single nuclear polymorphism for oxidative DNA repair and enzymatic antioxidants is 
important in determining the potential human cancer risk [34].
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ROS regulates tumor development including following steps: transformation 
[63], survival [64], proliferation [65], invasion [66], metastasis [67], and angiogen-
esis [68]. One study showed the oxidative stress may be positive correlation with 
lung cancer staging [69]. In breast carcinomas, 8-OHdG (a most widely used finger-
print of radical attack towards DNA) might be increased 8- to 17-fold in breast 
primary tumors compared with non-malignant breast tissue [70].
H2O2 plays an important role in carcinogenesis because it is capable of diffus-
ing throughout the mitochondria and across cell membranes and producing many 
types of cellular injury [71]. ROS may down-regulate the expression of the DNA 
mismatch repair genes (mutS homolog 2 and 6) and inhibit its enzymatic activity. 
ROS also induce the expression of DNA methyltransferases, leading to a total hyper-
methylation of the genome [72]. DNA methylation silence several tumor suppressor 
genes promoter, such as adenomatous polyposis coli (APC), cyclin-dependent 
kinase inhibitor-2 (CDKN-2), breast cancer susceptibility gene 1 (BRCA1), retino-
blastoma protein (Rb), and the DNA mismatch repair gene, human mutL homolog 
1 (hMLH1) [73, 74].
However, it is interesting that oxidative stress induces cancer, but also exists 
opposite condition. When ROS produced in large excess, they endanger the viability 
of the cancer cells, through the sustained activation of the cell cycle inhibitors [75]. 
To protect themselves from ROS-mediated toxicity, many types of cancers enhance 
the intrinsic antioxidant defenses, which make them dependent on the efficacy of a 
given ROS-detoxifying system. This poses an attractive target for anticancer therapy 
by using prooxidants or inhibiting of a chosen antioxidant system [76]. Whether 
ROS promote tumor cell survival or act as anti-tumorigenic agents depends on the 
cell and tissues, the location of ROS production, and the concentration of indi-
vidual ROS.
4. Mechanisms of Salvia miltiorrhiza in aging-associated CVD and cancer
4.1 Therapeutic properties of Danshen in aging-associated CVD
Salvianolic acids, especially SalA and SalB, have potent anti-oxidative capabili-
ties due to their polyphenolic structure. The cardiovascular protection of salvianolic 
acids include the following mechanisms: ROS scavengers, reduction of leukocyte-
endothelial adherence, inhibition of inflammation and metalloproteinases expres-
sion from aortic smooth muscle cells, and indirect regulation of immune function, 
and also competitive binding to target proteins to interrupt protein–protein interac-
tions [77].
SalA inhibits oxidative stress directly by scavenging the free radicals to improve 
the endothelial dysfunction [78], vascular smooth muscle cell proliferation [79], 
pulmonary arterial hypertension [80], and cardiac fibrosis. SalA can chelate Cu2+ 
and inhibit Cu2+-promoted oxidation of low-density lipoprotein to reduce the 
production of malondialdehyde which is the final product of polyunsaturated fatty 
acids peroxidation in a cell-free system [81]. Interesting, there is a study showed 
both Salvianolic acid and tanshinone contribute to the cardioprotective effect 
of Danshen. Tanshinone mainly inhibits intracellular calcium and cell adhesion 
pathways at an early stage after ischemic injury whereas Salvianolic acid acts mainly 
by decreasing apoptosis [82].
SalB protects human endothelial progenitor cells against oxidative stress-
mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and 
ERK1/2 signaling pathways and prevents oxidative-induced endothelial dysfunction 
via down-regulated NADPH oxidase 4 and eNOS expression [18].
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Cardiac fibrosis is a chronic harmful result of hypertension which may further 
advance to heart failure and increased matrix metalloproteinase-9 (MMP-9) 
contributes to the underlying mechanism. In neonatal cardiac fibroblast, SalA 
inhibited fibroblast migration, blocked myofibroblast transformation, inhibited 
secretion of intercellular adhesion molecule (ICAM), interleukin-6 (IL-6) and 
soluble vascular cell adhesion molecule-1 (sVCAM-1) as well as collagen induced 
by MMP-9. The inhibition on MMP-9 by SalA was further confirmed in cultured 
cardiac H9c2 cell overexpressing MMP-9 in vitro and in heart of spontaneously 
hypertensive rats (SHR) in vivo [83]. SalA targeted transgelin and had a protective 
effect on myocardium by stabilizing the transgelin-actin complex, modulating 
the reorganization of the actin cytoskeleton, facilitating F-actin bundling, further 
enhancing the contractility and blood flows of coronary arteries, and improving 
outcomes of myocardial ischemia [84]. SalB facilitates angiogenesis and alleviated 
cardiac fibrosis and cardiac remodeling in diabetic cardiomyopathy by suppressing 
insulin-like growth factor-binding protein 3 (IGFBP3) [85]. SalB can alleviate Ang 
II-induced cardiac fibrosis via suppressing the NF-κB pathway in vitro [86]. It is 
reported that treatment with 5% water-soluble extract of Danshen which contained 
SalB for 12 weeks lowers blood cholesterol and reduces atherosclerotic plaque 
formation in diet-induced hypercholesterolemic rabbits, which is associated with its 
ROS scavenging capacity (Table 1) [87].
Homocysteine (Hcy), a by-product of methionine metabolism, may lead to 
hyperhomocysteinemia which is the risk factors responsible for the development 
of several vascular diseases (thromboembolism, atherosclerosis, stroke, vascular 
diseases and dementia). The aqueous extracts of Danshen against vascular athero-
sclerotic lesions though inhibiting Hcy-induced rat smooth muscle cell line(A10) 
growth via the PKC/MAPK-dependent pathway, attenuated carbonyl-modification 
of specific cytoskeleton and chaperone proteins leading to cell type transformation, 
also, scavenging of ROS and subsequent modulation of protein carbonylation to 
inhibit cell proliferation [88]. Another study demonstrated the protective effect 
of Danshen extract against the Hcy-induced adverse effect on human umbilical 
vein endothelial cell and showed different effectiveness in protection according 
to the following descending order: Danshen aqueous extract, 3-(3,4-dihydroxy-
phenyl)-2-hydroxy-propionic acid (Danshensu), protocatechuic acid, catechin and 
protocatechualdehyde [89]. Danshensu decreases foam cell formation by reducing 
the expression of TNFα, ICAM-1, and ET-1 while increasing NO production, thus 
protecting the vascular endothelium from injury [90]. SalA markedly attenuated 
induction of MKP-3(mitogen-activated protein kinase phosphatases 3) and inhibi-
tion of eNOS expression and NO formation under endothelial ischemia/reperfusion 
condition [91].
Some clinical studies reported that the Danshen preparations in combination 
with Western medicine were more effective for treatment of various CVDs includ-
ing angina pectoris, myocardial infarction, hypertension, hyperlipidemia, and 
pulmonary heart diseases [92]. Our previous series studies showed the most com-
mon used single Chinese herbal products which prescribed by TCM Doctors during 
2000–2010 in Taiwan is Danshen (16.50% in ischemic stroke; 29.30% in ischemic 
heart disease; 3.95% in atrill fibrillation; 5.13% in heart failure) [36, 37, 93, 94]. 
There was nearly one-third lower stroke risk in ischemic heart disease patients with 
combination TCM than patients with non-TCM treatment (95% CI = 0.11–0.84, 
P = .02). The higher survival rate (P < .001) and the lower incidence of hemor-
rhagic stroke (P = .04) in ischemic heart disease patients with TCM treatment was 
reported [95]. Compared to non-TCM users, the stroke risk was significantly lower 
in TCM users with atrial fibrillation who were female or younger than 65 years, 
but not in males, people more than 65 years old, or people with comorbidities [93]. 
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One randomized controlled trial showed Salvia Miltiorrhiza Depside Salt combined 
with aspirin is a clinically effective and safe intervention to treat adults aged 35 and 
older with stable angina pectoris without adverse drug reactions such as bleeding 
tendency occurred [96].
4.2 Therapeutic properties of Danshen in cancer
SalA and SalB have been reported to owe anti-cancer, anti-inflammatory and 
cardioprotective activities not only through inducing apoptosis, halting cell cycle 
Component Pathology of CVD Mechanism References
Salvianolic 
acid A
Endothelial dysfunction ⊕ microvascular remodeling [78]
Vascular smooth muscle 
cell proliferation





↓ right ventricular systolic pressure
↓ hypertrophic damage of myocardium, 
parenchymal injury and collagen deposition 
in the lungs
[80]




hypertension ⊝ MMP-9 [83]
myocardial ischemia stabilize the transgelin-actin complex
modulate the reorganization of the actin 
cytoskeleton
⊕ F-actin bundling,





Endothelial dysfunction modulating Akt/mTOR/4EBP1, p38 
MAPK/ATF2
↑ ERK1/2 signaling pathways





⊝ atherosclerotic plaque formation
⊕ scavenging ROS
[87]
Cardiac fibrosis ⊝ fibroblast migration and myofibroblast 
transformation










↑: increase; ↓: decrease; ↔: no change; ⊝: inhibit; ⊕: promote. cAMP, cyclic adenosine monophosphate; PKA, protein 
kinase A; CREB, cAMP-response element binding protein; LDL, low-density lipoprotein; MDA, malondialdehyde; 
MMP-9, Matrix metallopeptidase 9; Akt, protein kinase B; mTOR, mechanistic target of rapamycin; 4EBP1, 
Eukaryotic translation initiation factor 4E-binding protein 1; p38 MAPK, mitogen-activated protein kinases;  
ATF2, Activating Transcription Factor 2; ERK1, extracellular signal-regulated kinase 1; Nox4, NADPH oxidase 4; 
eNOS, Endothelial Nitric Oxide Synthase; ROS, reactive oxygen species; ICAM, intercellular adhesion  
molecule; IL-6, interleukin-6; sVCAM-1, soluble vascular cell adhesion molecule-1; NF-κB, nuclear factor  
kappa-light-chain-enhancer of activated B cells; IGFBP3, insulin-like growth factor-binding protein 3.
Table 1. 
The main antioxidative mechanisms of Salvia miltiorrhiza (Danshen) in CVD.
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and adjourning metastasis by targeting multiple deregulated signaling networks of 
cancer but also sensitizing cancer cells to chemo-drugs [97].
Acting to protect the organism against these harmful pro-oxidants is a complex 
system of enzymatic antioxidants (e.g., superoxide dismutase (SOD), glutathione 
peroxidase, glutathione reductase, catalase) and nonenzymatic antioxidants (e.g., 
glutathione, vitamins C and D) [98].
SalA elevated ROS levels, downregulated P-glycoprotein, and triggered apopto-
sis by increasing caspase-3 activity and upregulating Bax expression, while down-
regulating Bcl-2 expression and disrupting the mitochondrial membrane potential 
in multidrug resistance MCF-7 human breast cancer cells [99]. In lung cancer, SalA 
could increase the chemotherapeutic efficacy of cisplatin by enhanced sensitivity to 
cisplatin in A549/DDP cells mainly through suppression of the c-met/AKT/mTOR 
signaling pathway [100]. In addition, SalA considerably suppressed the migra-
tive and invasive activity of human NPC cells but not presented cytotoxicity. In 
SalA-treated NPC cells, the activity and expression of matrix metalloproteinase-2 
(MMP-2), a key regulator of cancer cell invasion, were reduced. Additionally, the 
presence of high concentrations of SalA dramatically abolished the activation of 
focal adhesion kinase (FAK) and moderately inhibited the phosphorylation of Src 
and ERK in NPC cells [101].
The anti-tumor effect of SalB is via inhibiting the expression of glucosylce-
ramide and GM3 synthases, and then increases the ceramide accumulation and 
ceramide-mediated Triple-negative breast cancer cell apoptosis. [102]. One study 
indicated SalB induced cell death and triggered autophagy in HCT116 and HT29 
cells in a dose-dependent manner, and it is as a novel autophagy inducer in colorec-
tal cancer cells through the suppression of AKT/mTOR pathway [103]. Besides, 
Component Cancer Mechanism References
Salvianolic 
acid A
Non-small cell lung 
cancer
↑ efficacy of DDP
⊝c-met/AKT/mTOR signaling pathway
[100]
Breast cancer ↑ ROS in resistant cells
↑ apoptosis via caspase-3 activity, disrupted 
mitochondrial membrane potential, ↓ Bcl-2 
and










Colorectal cancer ⊕ cancer cell death and autophagy
⊝ AKT/mTOR pathway
[103]
Head and neck 
carcinoma
⊝ COX-2/PGE-2 pathway
⊕ the promotion of apoptosis
⊕ angiogenesis.
[109]
Hepatocellular cancer ↓ cytotoxicity of doxorubicin
↓ ROS by enhancing the expression of SOD 
and decreasing NADPH oxidase
[104]
Gastric cancer ↓ the resistance to DDP via AKT/mTOR 
pathway
[105]
↑: increase; ↓: decrease; ↔: no change; ⊝: inhibit; ⊕: promote. ROS, reactive oxygen species; DDP, cisplatin; AKT, 
protein kinase B; mTOR, mechanistic target of rapamycin; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X 
protein; FAK, focal Adhesion Kinase; ERK, extracellular signal regulated kinase; COX-2/PGE-2; SOD; NADPH.
Table 2. 
The therapeutic effect mechanism of polyphenols of Salvia miltiorrhiza (Danshen) in common cancers.
Phenolic Compounds
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SalB reduced the cytotoxicity of doxorubicin through scavenging ROS generated by 
doxorubicin in HepG2 cells and enhance the expression of SOD and decrease that 
of NADPH oxidase, which resulted in the elimination of ROS [104]. Sal-B regulated 
proliferation, epithelial-mesenchymal transition (EMT) and apoptosis to reduce the 
resistance to cisplatin via AKT/mTOR pathway in cisplatin-resistant gastric cancer 
cells [105].
Rosmarinic acid (RA) inhibited non-small cell lung cancer (NSCLC) by induc-
ing G1 phase cell cycle arrest, apoptosis and the sensitivity of cisplatin-resistant 
cell via activating MAPK, enhancing p21 and p53 expression, and inhibiting the 
expression of P-gp and MDR1 [106]. RA reverses cisplatin resistance of NSCLS by 
activating the MAPK signaling pathway.
Most of the currently available chemotherapeutic and radiotherapeutic agents 
kill cancer cells by increasing ROS stress. Thus, both ROS-elevating and ROS-
eliminating strategies have been developed for cancer therapy. As we know either 
chemotherapy or radiotherapy was usually associate with uncomfortable side-effects 
which are burdens to clinical physicians. Our previous researches find the aqueous 
extract of Danshen has shown anticancer as well as antioxidant effects, besides, it 
could prevent or mitigate the causative cardiomyopathy through controlling multiple 
targets without compromising the efficacy of chemotherapy (Table 2) [107, 108].
5. Conclusion
The current epidemiologic data show the incremental trend of CVD and cancer 
prevalence, mortality as well as disease burden expected in the next 40 years. The 
prevention of disease becomes the main lesson from now on to the future. Danshen 
plays a role as anti-oxidative agent and its therapeutic effects in diseases includ-
ing age-associated CVDs and cancer are confirmed in many studies. Traditional 
Chinese medicine might be an option for treatment.
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Abbreviations
CVD Cardiovascular disease
ROS Reactive oxygen species
TCM Traditional Chinese medicine
LV Left ventricular
eNOS Endothelial nitric oxide synthetase
NO Nitric oxide
SalA Salvianolic acid A
SalB Salvianolic acid B






NSCLC Non-small cell lung cancer
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